| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.65 | 0.02 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |